M. Armengaud

517 total citations
48 papers, 385 citations indexed

About

M. Armengaud is a scholar working on Epidemiology, Microbiology and Molecular Medicine. According to data from OpenAlex, M. Armengaud has authored 48 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 14 papers in Microbiology and 9 papers in Molecular Medicine. Recurrent topics in M. Armengaud's work include Bacterial Infections and Vaccines (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). M. Armengaud is often cited by papers focused on Bacterial Infections and Vaccines (13 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). M. Armengaud collaborates with scholars based in France, United States and Canada. M. Armengaud's co-authors include Michael Barza, Sheldon H. Landesman, Michael L. Corrado, Charles E. Cherubin, B. Marchou, J.Ch. Auvergnat, P. Massip, P. Chavanet, C Théodore and Hervé Tilly and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

M. Armengaud

45 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Armengaud France 10 192 134 106 101 57 48 385
C Brandimarte Italy 8 97 0.5× 29 0.2× 52 0.5× 50 0.5× 114 2.0× 32 306
M. Ridley United Kingdom 11 159 0.8× 45 0.3× 45 0.4× 67 0.7× 212 3.7× 18 488
Robert E. Levitz United States 10 255 1.3× 44 0.3× 62 0.6× 71 0.7× 113 2.0× 15 440
S Schönwald Croatia 12 337 1.8× 61 0.5× 74 0.7× 131 1.3× 62 1.1× 25 507
Raymond Duperval Canada 12 222 1.2× 48 0.4× 72 0.7× 19 0.2× 169 3.0× 22 399
R. V. McCloskey United States 9 70 0.4× 76 0.6× 84 0.8× 17 0.2× 75 1.3× 19 316
William J. Holloway United States 13 318 1.7× 82 0.6× 112 1.1× 74 0.7× 299 5.2× 29 581
Gladys Mihara United States 7 422 2.2× 61 0.5× 66 0.6× 55 0.5× 45 0.8× 8 524
Ingrid Ehrhard Germany 13 297 1.5× 61 0.5× 41 0.4× 314 3.1× 44 0.8× 25 454
Paola Nardini Italy 13 155 0.8× 83 0.6× 19 0.2× 211 2.1× 29 0.5× 26 460

Countries citing papers authored by M. Armengaud

Since Specialization
Citations

This map shows the geographic impact of M. Armengaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Armengaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Armengaud more than expected).

Fields of papers citing papers by M. Armengaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Armengaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Armengaud. The network helps show where M. Armengaud may publish in the future.

Co-authorship network of co-authors of M. Armengaud

This figure shows the co-authorship network connecting the top 25 collaborators of M. Armengaud. A scholar is included among the top collaborators of M. Armengaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Armengaud. M. Armengaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cavallo, J.-D., et al.. (2000). Infections urinaires en pratique de ville: évolution des etiologies et de la sensibilité aux antibiotiques d'Escherichia coli. Médecine et Maladies Infectieuses. 30. s234–s234. 1 indexed citations
2.
Cavallo, J.-D., et al.. (1997). Les entérobactéries isolées d'infections urinaires en pratique de ville : étude AFORCOPIBIO 1995. Médecine et Maladies Infectieuses. 27. 642–645. 16 indexed citations
3.
Lepargneur, Jean-Pierre, et al.. (1994). Evolution des fréquences d'isolement et de la résistance des souches d'Escherichia coli isolées d'infections urinaires en pratique de ville de 1986 à 1993. Médecine et Maladies Infectieuses. 24. 539–542. 11 indexed citations
4.
Marchou, B., et al.. (1992). Itraconazole et histoplasmose ganglionnaire africaine chez un sujet non immunodéprimé. Médecine et Maladies Infectieuses. 22(2). 234–235. 3 indexed citations
5.
Roithmann, Sérgio, Michel Toledano, J.M. Tourani, et al.. (1991). HIV-associated non-Hodgkin's lymphomas: Clinical characteristics and outcome. The experience of the French Registry of HIV-associated Tumors*. Annals of Oncology. 2(4). 289–295. 39 indexed citations
6.
Armengaud, M., et al.. (1989). [Frequency of germ isolation from urinary infections in community practice; their sensitivity to 7 antibiotics including a combination of amoxicillin and clavulanic acid. Evaluation on 1611 samples].. PubMed. 37(5). 402–5. 4 indexed citations
7.
Marchou, B., et al.. (1988). [Shortened antibiotic therapy of meningococcal meningitis: 5-day administration of ceftriaxone].. PubMed. 36(5 Pt 2). 735–7. 7 indexed citations
8.
Marchou, B., et al.. (1988). Meningites bacteriennes du sujet age. Médecine et Maladies Infectieuses. 18. 383–383. 1 indexed citations
9.
Vittecoq, Daniel, R Roué, C Mayaud, et al.. (1987). ACQUIRED IMMUNODEFICIENCY SYNDROME AFTER TRAVELLING IN AFRICA: AN EPIDEMIOLOGICAL STUDY IN SEVENTEEN CAUCASIAN PATIENTS. The Lancet. 329(8533). 612–615. 28 indexed citations
10.
May, T., et al.. (1986). Pasteurelloses par inoculation cutanée. Résultats de l'étude multicentrique. Médecine et Maladies Infectieuses. 16. 36–39. 2 indexed citations
11.
Auvergnat, J.Ch., J Lemozy, P. Massip, & M. Armengaud. (1985). Traitement de la fièvre typhoïde par la ceftriaxone. Médecine et Maladies Infectieuses. 15(8-9). 454–456. 4 indexed citations
12.
Auvergnat, J.Ch. & M. Armengaud. (1985). Bilan et perspectives d'une nouvelle céphalosporine: la ceftriaxone. La Revue de Médecine Interne. 6(2). 187–192. 2 indexed citations
13.
Armengaud, M.. (1982). Variétés sémiologiques des infections à staphylocoques.. La Revue du praticien. 32. 1 indexed citations
14.
Landesman, Sheldon H., et al.. (1981). Past and current roles for cephalosporin antibiotics in treatment of meningitis. The American Journal of Medicine. 71(4). 693–703. 104 indexed citations
15.
Armengaud, M., et al.. (1980). Cefotaxime in the treatment of septicaemia and endocarditis. Journal of Antimicrobial Chemotherapy. 6(suppl A). 263–268. 5 indexed citations
16.
Massip, P., et al.. (1979). Penetration of Cefoxitin into Cerebrospinal Fluid of Dogs with and without Experimental Meningitis. Clinical Infectious Diseases. 1(1). 132–133. 12 indexed citations
17.
Auvergnat, J.Ch., et al.. (1976). Pharmacocinétique comparée de différents antibiotiques dans le L.C.R. en fonction du mode d’administration intra-veineux. Médecine et Maladies Infectieuses. 6(4). 125–133. 1 indexed citations
18.
19.
Armengaud, M., et al.. (1962). [2-Dehydro-emetine in very severe forms of colic amebiasis].. PubMed. 70. 991–4. 2 indexed citations
20.
Armengaud, M., et al.. (1961). 2-Dehydro-Emetine in the Treatment of Amoebiasis.. Bulletin de la Société de pathologie exotique. 54(1). 29–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026